Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo

• Felix Scheuplein,

  Affiliation NKT Therapeutics, Inc., Waltham, MA, United States of America

  ⨯
• Deanna J. Lamont,

  Affiliation The Jackson Laboratory, Bar Harbor, ME, United States of America

  ⨯
• Matthew E. Poynter,

  Affiliation The University of Vermont, Department of Medicine, Burlington, VT, United States of America

  ⨯
• Jonathan E. Boyson,

  Affiliation The University of Vermont, Department of Medicine, Burlington, VT, United States of America

  ⨯
• David Serreze,

  Affiliation The Jackson Laboratory, Bar Harbor, ME, United States of America

  ⨯
• Lennart K. A. Lundblad,

  Affiliation The University of Vermont, Department of Medicine, Burlington, VT, United States of America

  ⨯
• Robert Mashal,

  Affiliation NKT Therapeutics, Inc., Waltham, MA, United States of America

  ⨯
• Robert Schaub

  * E-mail: rschaub@nktrx.com

  Affiliation NKT Therapeutics, Inc., Waltham, MA, United States of America

  ⨯